Casey Niall 4

What Happened Casey Niall, Chief IP Officer and a director of Carlsmed, was granted 44,977 restricted stock units (RSUs) on January 28, 2026. The award has a grant price of $0.00 (i.e., no cash paid) — RSUs are a form of equity compensation rather than a market purchase or sale. The filing was submitted on January 30, 2026.

Key Details

• Transaction date and type: 2026-01-28 — Award/Grant (code A)
• Shares granted: 44,977 RSUs; grant price reported as $0.00
• Shares owned after transaction: Not specified in this Form 4
• Vesting/footnote: Each RSU converts to one share of common stock; vesting in three equal annual installments beginning on the first anniversary of the grant date (per filing footnote)
• Filing timeliness: Reported on 2026-01-30 (within the usual two-business-day Form 4 window)

Context RSUs are compensation that vest over time and do not indicate an immediate market purchase or sale. They provide potential future equity if and when vesting conditions are met; they are commonly used for executive/director pay and do not by themselves signal a buy or sell opinion. No options were exercised, no shares were sold, and no tax-withholding or other derivative-related actions are noted in this filing.